Soon on demand: Quarterly Focus on Breast Cancer

November 22, 2017

  • Share this post:

Publications in peer-reviewed journals are a major source for keeping up with the latest developments in your field. However, you may not have always sufficient time to study (difficult) publications thoroughly and to determine the impact on your clinical practice. To support you, has developed a new program format, the ‘ Quarterly Focus ’, which brings together an expert panel and the authors of relevant, selected publications in an innovative way to explain and discuss the new data.

Two pivotal, international publications from the past few months will be clarified by one of the authors and will be thoroughly discussed by an expert panel including the author. The program will give you the unique possibility to gain more insight into the selected publications and to interact with the expert panel and the authors.

The expert panel consists of:

  • Gabe Sonke, MD, Ph.D, medical oncologist, NKI-AVL Amsterdam, Netherlands
  • Ester Siemerink, MD, Ph.D, medical oncologist, Ziekenhuis Groep Twente, Hengelo/Almelo, Netherlands
  • Rianne Oosterkamp, MD, medical oncologist, Haaglanden Medisch Centrum, Den Haag, Netherlands

Invited speakers:

Prof. George Sledge, MD, medical oncologist
Stanford University School of Medicine, California, US
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
J Clin Oncol, 2017

Prof. Laura van ‘t Veer, molecular biologist
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, US
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades
JAMA Oncol, 2017

This program is editorially independent and is financially supported by: